Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.22% | 177.90 | 0.7% | $1343.27m | |
| MRK | Merck & Co., Inc. | 0.44% | 91.57 | 0.7% | $1172.95m | |
| PFE | Pfizer Inc. | -1.23% | 51.79 | 0.9% | $1100.09m | |
| LLY | Eli Lilly & Co. | -1.12% | 320.61 | 1.1% | $1034.00m | |
| BMY | Bristol-Myers Squibb Co. | -0.96% | 76.26 | 1.0% | $998.17m | |
| ABBV | AbbVie, Inc. | -0.75% | 152.02 | 1.9% | $951.59m | |
| AZN | AstraZeneca Plc | -1.01% | 65.40 | 1.0% | $437.00m | |
| SGEN | Seagen Inc. | 0.64% | 178.07 | 5.7% | $317.91m | |
| TPTX | Turning Point Therapeutics, Inc. | -0.12% | 75.16 | 0.0% | $287.74m | |
| GSK | GSK Plc | -0.23% | 43.43 | 0.2% | $275.82m | |
| HZNP | Horizon Therapeutics Plc | 0.75% | 80.36 | 5.4% | $163.02m | |
| NVS | Novartis AG | -0.98% | 83.70 | 0.2% | $162.95m | |
| MRTX | Mirati Therapeutics, Inc. | 3.45% | 69.45 | 1.6% | $151.78m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 1.31% | 147.76 | 8.1% | $142.36m | |
| NVO | Novo Nordisk A/S | -0.75% | 110.60 | 0.1% | $142.16m |
Company Profile
ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.